ライフサイエンスコーパス: Mycoplasma

1 n of the cells by a human-specific strain of mycoplasma.

2 Prevotella, Selenomonas, Streptococcus, and Mycoplasma.

3 ibody-binding protein (Protein M) from human mycoplasma.

4 were found to be infected by this hemotropic mycoplasma.

5 nisms of the myxobacteria, flavobacteria and mycoplasmas.

6 entially key role in the immunity evasion by mycoplasmas.

7 biting flies by testing them for hemotropic mycoplasmas.

8 Treponema (34%), Mycoplasma (29%) and Porphyromonas (15%) were the most a

9 colonization yet cilia provide a conduit for mycoplasma access to the host cell surface and suggest a

10 We created heterogeneity in Mycoplasma agassizii exposure (the putative bacterial ag

11 We show here that mycoplasmas also produce glycoproteins and hence have gl

12 Mycoplasma amphoriforme has been associated with infecti

13 Mycoplasma amphoriforme is a recently described organism

14 Mycoplasma amphoriforme isolates form a closely related

15 sis, we observed infrequent co-occurrence of Mycoplasma and bacteria vaginosis associated bacteria 3

16 e extend the microbial activators of Lcn2 to mycoplasma and describe studies in which the mechanism o

17 2) is a by-product of glycerol metabolism in mycoplasmas and has been shown to cause cytotoxicity for

18 encoding the MIB-MIP system are specific to mycoplasmas and have been disseminated by horizontal gen

19 homologs found in the majority of pathogenic mycoplasmas and often in multiple copies.

20 e bacilli, Staphylococcus aureus, Chlamydia, Mycoplasma, and Legionella are each identified in 2%-5%

21 e genera Methylobacterium, Acinetobacter and Mycoplasma, appear to drive these changes, indicating th

22 ing knowledge that species of Mannheimia and Mycoplasma are important pathogens in pneumonia and otit

23 Mycoplasmas are "minimal" bacteria able to infect humans

24 Mycoplasmas are notorious contaminants of cell culture a

25 Mycoplasmas are small bacterial commensals or pathogens

26 tinct SAgs, staphylococcal enterotoxin B and Mycoplasma arthritidis mitogen, on influenza virus- and/

27 Mycoplasma arthritidis-derived mitogen (MAM) is a member

28 ine, 2'-deoxyuridine and thymidine inhibited mycoplasma-associated dFdC deamination but were efficien

29 Mycoplasma bacteria, with the smallest known genomes amo

30 lycoprotein laminin by 95% failed to inhibit mycoplasma binding to sulfatide, suggesting that P1 does

31 However, mycoplasmas bound to sulfatide exhibited no gliding moti

32 Mycoplasma bovis causes pneumonia, pharyngitis, otitis,

33 Mycoplasma bovis is a major bovine pathogen associated w

34 al diarrhea virus, Mannheimia haemolytica or Mycoplasma bovis.

35 Unique among mycoplasmas, Ca.

36 Mycoplasma canis can infect many mammalian hosts but is

37 The minimalist bacterium Mycoplasma capricolum possesses two homologs of trmFO, b

38 , Mycoplasma mycoides subsp. capri (Mmc) and Mycoplasma capricolum subsp. capricolum (Mcap), and the

39 PP) is a highly contagious disease caused by Mycoplasma capricolum subsp. capripneumoniae that affect

40 m is among the most economically significant mycoplasmas causing production losses in poultry.

41 e advantage of the special properties of the mycoplasma cell reveal that this motor propels cells in

42 sma, cytoplasm, synaptic vesicles, HIV and a mycoplasma cell.

43 This study reveals a metabolically unique mycoplasma colonizing a premature neonate, and establish

44 Lcn2 is strongly and enduringly activated by mycoplasma components that stimulate the innate immune r

45 ent culture medium (i.e. tumor cell-free but mycoplasma-containing) of mycoplasma-infected tumor cell

46 Lastly, we examined the relationship between mycoplasma contamination and host gene expression in a s

47 In all, this study suggests mycoplasma contamination is still prevalent today and po

48 ity of dFdC in such cells is attributed to a mycoplasma cytidine deaminase causing rapid drug catabol

49 Adherence assays with radiolabeled mycoplasmas demonstrated a dramatic reduction in binding

50 Additionally, mycoplasma-derived pyrimidine nucleoside phosphorylase (

51 identified by the ePlex RPP, NxTAG RPP, and Mycoplasma Direct assays, respectively.

52 respiratory panel (RP), the Meridian Alethia Mycoplasma Direct, the GenMark ePlex respiratory pathoge

53 amplification (LAMP) system, the illumigene Mycoplasma DNA amplification assay (Meridian Bioscience,

54 ation sequencing technology in applied avian mycoplasma epidemiology at both local and global levels.

55 of 10 pigs each: (i) negative control, (ii) Mycoplasma flocculare (strain 27399), (iii) Mycoplasma h

56 se finch populations, the bacterial pathogen Mycoplasma gallisepticum (MG) has been increasing in vir

57 ches and the conjunctival bacterial pathogen Mycoplasma gallisepticum (MG), to experimentally examine

58 ion using archived isolates of the bacterium Mycoplasma gallisepticum collected during sequential eme

59 Mycoplasma gallisepticum colonizes the chicken respirato

60 h management, vaccination, and surveillance, Mycoplasma gallisepticum continues to cause significant

61 the GroEL protein (heat shock protein 60) of Mycoplasma gallisepticum could induce apoptosis in perip

62 Mycoplasma gallisepticum is among the most economically

63 Mycoplasma gallisepticum is an avian respiratory and rep

64 ype (WT) R(low) strain of the avian pathogen Mycoplasma gallisepticum is capable of producing H2O2 wh

65 Mycoplasma gallisepticum is the most virulent and econom

66 Mycoplasma gallisepticum is the primary etiologic agent

67 h annexin A2, a novel virulence mechanism in Mycoplasma gallisepticum Our findings lead to a better u

68 The GroEL gene from Mycoplasma gallisepticum was cloned and expressed in Esc

69 We inoculated 55 isolates of Mycoplasma gallisepticum, collected over 20 y from outbr

70 Mycoplasma gallisepticum, known primarily as a respirato

71 The avian pathogen Mycoplasma gallisepticum, the etiological agent of chron

72 Mycoplasma gallisepticum, the primary etiologic agent of

73 outbreak strains of the bacterial pathogen, Mycoplasma gallisepticum, which jumped from poultry into

74 sease, Mycoplasmal conjunctivitis, caused by Mycoplasma gallisepticum.

75 r understanding of molecular pathogenesis in Mycoplasma gallisepticum.

76 sae infected with virulent, immunopathologic Mycoplasma gallisepticum; however, mechanisms delineatin

77 Two affiliated close to Spiroplasma and Mycoplasma genera, one to chlamydial 'Candidatus Syngnam

78 arator for clinical validation of the Aptima Mycoplasma genitalium (AMG) assay, an in vitro diagnosti

79 Chlamydia trachomatis (CT) and Mycoplasma genitalium (MG) are two highly prevalent bact

80 Macrolide-resistance in Mycoplasma genitalium (MG) exceeds 50% in many regions a

81 Macrolide resistance in Mycoplasma genitalium (MG) exceeds 50% in many regions,

82 ts, Chlamydia trachomatis (CT) in 13 (9.0%), Mycoplasma genitalium (MG) in 4 (2.8%), HPV16 in 38 (26.

83 Mycoplasma genitalium (MG) infections are a growing conc

84 Although Mycoplasma genitalium (MG) is an acknowledged cause of n

85 Mycoplasma genitalium (MG) is an emerging pathogen among

86 Mycoplasma genitalium (MG) is an emerging sexually trans

87 Mycoplasma genitalium (MG) is associated with nongonococ

88 Antimicrobial resistance in Mycoplasma genitalium (MG), a cause of urethritis, is a

89 To determine the prevalence of Mycoplasma genitalium and its association with cervical

90 Mycoplasma genitalium and other NGU pathogens were detec

91 There is increasing concern about Mycoplasma genitalium as a cause of urethritis, cervicit

92 ral pathogens, and the literature supporting Mycoplasma genitalium as an etiology of urethritis is gr

93 16 to 82 years, were tested with the Aptima Mycoplasma genitalium assay, an investigational transcri

94 Mycoplasma genitalium causes persistent urogenital tract

95 Chlamydia trachomatis and Mycoplasma genitalium coinfections were evaluated using

96 The human pathogen Mycoplasma genitalium employs homologous recombination t

97 Mycoplasma genitalium has been causally linked with nong

98 Mycoplasma genitalium has been significantly and nonsign

99 -site genital and extragenital screening for Mycoplasma genitalium in 102 asymptomatic Air Force memb

100 irus (HIV) from Johannesburg (2012) detected Mycoplasma genitalium in 7.4% (95% confidence interval [

101 Although the pathogenic role of Mycoplasma genitalium in male urethritis is clear, fewer

102 Mycoplasma genitalium in our study displayed the clinica

103 genes and produced evidence for at least two Mycoplasma genitalium in silico minimal genomes.

104 To determine the association between Mycoplasma genitalium infection and female reproductive

105 Mycoplasma genitalium infection was significantly associ

106 ydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium infection.

107 The prevalence rates of Mycoplasma genitalium infections and coinfections with o

108 at 4.9% (95% credible interval, .4-14.1%) of Mycoplasma genitalium infections in women progress to pe

109 Mycoplasma genitalium is a common cause of nongonococcal

110 Mycoplasma genitalium is a common sexually transmitted i

111 Mycoplasma genitalium is a frequent undiagnosed cause of

112 Mycoplasma genitalium is a sexually transmitted bacteriu

113 Mycoplasma genitalium is an emerging sexually transmitte

114 Mycoplasma genitalium is an emerging sexually transmitte

115 Mycoplasma genitalium is an important and emerging agent

116 Mycoplasma genitalium is an underappreciated cause of hu

117 The prevalence of Mycoplasma genitalium is high in vulnerable populations

118 Mycoplasma genitalium is increasingly appreciated as a c

119 Although Mycoplasma genitalium is increasingly recognized as a se

120 sis of fluoroquinolone treatment failure for Mycoplasma genitalium is poorly understood.

121 The incubation period for NGU caused by Mycoplasma genitalium is probably longer than for NGU ca

122 Mycoplasma genitalium is the smallest self-replicating b

123 Mycoplasma genitalium is very difficult to grow in cultu

124 Rising macrolide and quinolone resistance in Mycoplasma genitalium necessitate new treatment approach

125 article lays out the research priorities for Mycoplasma genitalium research agreed upon by the partic

126 on (TMA), residual material was subjected to Mycoplasma genitalium research-use-only TMA.

127 Mycoplasma genitalium samples from cases failing moxiflo

128 Additional Trichomonas vaginalis and Mycoplasma genitalium screening found 17.4% and 23.9% of

129 plification test (NAAT) for the detection of Mycoplasma genitalium Seven urogenital specimen types (n

130 istance and microbiological cure in men with Mycoplasma genitalium urethritis during 2013-2015 and co

131 d amplification in vitro diagnostic test for Mycoplasma genitalium were analyzed to describe the prev

132 uary 2015 using the following search terms: (Mycoplasma genitalium) AND (azithromycin OR zithromax OR

133 ith minimal genomes (Buchnera aphidicola and Mycoplasma genitalium).

134 Mycoplasma genitalium, a human pathogen associated with

135 recent bacterial vaginosis (BV) and incident Mycoplasma genitalium, a sexually transmitted bacterium

136 hlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis infecti

137 w nucleic acid amplification test (NAAT) for Mycoplasma genitalium, B.

138 risk for acquiring STIs, the prevalences of Mycoplasma genitalium, Chlamydia trachomatis, Neisseria

139 plasmas, such as the emergent human pathogen Mycoplasma genitalium, developed a complex polar structu

140 etween 2000 and 2016, using the search terms Mycoplasma genitalium, M. genitalium, diagnosis, and det

141 hogenicity factors of Gardnerella vaginalis, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gon

142 nfected MSM (Neisseria gonorrhoeae, P = .03; Mycoplasma genitalium, P = .04; HSV-2, P = .001; and a t

143 eisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, adenovirus

144 's experience building a whole-cell model of Mycoplasma genitalium, we identified several significant

145 citis is aimed at Chlamydia trachomatis, but Mycoplasma genitalium, which also commonly causes undiag

146 tibiotic regimens in a prospective cohort of Mycoplasma genitalium-infected participants, and factors

147 ublished) whole-cell model for the bacterium Mycoplasma genitalium.

148 pleted 629,409-bp 'Mnola' genome (Candidatus Mycoplasma girerdii str.

149 qualitatively and quantitatively the role of mycoplasma gliding motility in the colonization pattern

150 etected; however, infection with "Candidatus Mycoplasma haematoparvum" and a potentially novel, but i

151 CMhm) (15.7% guigna; 10.3% domestic cat) and Mycoplasma haemofelis (Mhf) (9.8% guigna, 6.1% domestic

152 In 2017, we detected DNA from "Candidatus Mycoplasma haemohominis" in the blood of a Melanesian pa

153 fections are mostly chronic, suggesting that mycoplasmas have developed means to evade the host immun

154 One had high abundance of Mycoplasma hominis and other had high abundance of an un

155 Mycoplasma hominis and Ureaplasma parvum do not appear t

156 Mycoplasma hominis identification was confirmed using se

157 Invasive and disseminated Mycoplasma hominis infections are well recognized but un

158 Mycoplasma hominis is a commensal genitourinary tract or

159 Among human mycoplasmas, Mycoplasma hominis is described as a commensal bacterium

160 Mycoplasma hominis isolates were subjected to whole-geno

161 Mycoplasma hominis should be considered a cause of donor

162 Mycoplasma hominis was detected by culture and qPCR in 2

163 Mycoplasma hominis was transmitted through amniotic tiss

164 aginae, Gardnerella vaginalis, lactobacilli, Mycoplasma hominis, and the human albumin gene (for qual

165 ardnerella vaginalis, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Streptococcus

166 eisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma hominis, Ureaplasma species, and yeast.

167 umoniae (MpnEf-Tu), and the porcine pathogen Mycoplasma hyopneumoniae (MhpEf-Tu).

168 Mycoplasma hyopneumoniae is an economically significant

169 Mycoplasma flocculare (strain 27399), (iii) Mycoplasma hyorhinis (strain 38983), (iv) Mycoplasma hyo

170 Proteases from Mycoplasma hyorhinis, Legionella pneumophila, Streptococ

171 ycytidine; dFdC) was severely compromised in Mycoplasma hyorhinis-infected tumor cell cultures.

172 i) Mycoplasma hyorhinis (strain 38983), (iv) Mycoplasma hyosynoviae (strain 34428), and (v) M. hyopne

173 The first component, Mycoplasma Ig binding protein (MIB), is an 83-kDa protei

174 The second component, Mycoplasma Ig protease (MIP), is a 97-kDa serine proteas

175 (defined as >/=100 reads/million mapping to mycoplasma in one or more samples).

176 s, our findings suggest that the presence of mycoplasmas in the tumor microenvironment could be a lim

177 re to MALP-2 and is persistently elevated in mycoplasma infected cells.

178 in inflammatory infiltrates in the lungs of mycoplasma-infected mice.

179 m and related cytostatic activity of dFdC in mycoplasma-infected tumor cells was therefore also (part

180 umor cell-free but mycoplasma-containing) of mycoplasma-infected tumor cells.

181 ort the need to constantly monitor cells for mycoplasma infection and keep stored samples of all cell

182 ies into venules in the airways of mice with Mycoplasma infection and that TNFalpha signaling is nece

183 hanism of Lcn2 gene regulation by MALP-2 and mycoplasma infection was investigated in mouse mammary e

184 rrent available methods for the diagnosis of Mycoplasma infection, including cultivation, serological

185 hanges in lipid content of cell lines due to mycoplasma infection.

186 Mycoplasma infections include a spectrum of clinical man

187 o amplification was obtained from 71 related Mycoplasma isolates or from the Acholeplasma or the Past

188 es belonging to a novel, as-yet-uncultivated mycoplasma (lineage 'Mnola') in the oral cavity of a pre

189 Mycoplasma lipoproteins play a relevant role in pathogen

190 < 0.001) were significantly associated with mycoplasma-mapped read counts.

191 Ninety percent of mycoplasma-mapped reads aligned to ribosomal RNA.

192 rotein-A (SP-A) binds live M. pneumoniae and mycoplasma membrane fractions (MMF) with high affinity.

193 rences in levels of SP-A binding to non-live mycoplasma membrane fractions that were dependent on the

194 uminex NxTAG RPP, the ELITech ELITe InGenius Mycoplasma MGB research use only (RUO) PCR, and the Spee

195 Mycoplasma mobile carries out gliding motility using a n

196 om that of other gliding bacteria, including Mycoplasma mobile.

197 ntal information available on its precursor, Mycoplasma mycoides capri, we assembled a near-complete

198 e the 1079-kilobase pair synthetic genome of Mycoplasma mycoides JCVI-syn1.0.

199 reported using two closely related bacteria, Mycoplasma mycoides subsp. capri (Mmc) and Mycoplasma ca

200 Mycoplasma mycoides subsp. capri (Mmc) and subsp. mycoid

201 oats were infected with the caprine pathogen Mycoplasma mycoides subsp. capri or an engineered mutant

202 ious respiratory disease of cattle caused by Mycoplasma mycoides subsp. mycoides.

203 nally characterize a two-protein system from Mycoplasma mycoides subspecies capri that is involved in

204 of the small-ribosomal subunit (16S) RNA of Mycoplasma mycoides, by combining the CRISPR/Cas9 system

205 Among human mycoplasmas, Mycoplasma hominis is described as a commen

206 ission of the pneumonia-associated bacterium Mycoplasma ovipneumoniae in domestic sheep, domestic goa

207 cally in infectiousness or susceptibility to Mycoplasma ovipneumoniae, an agent responsible for bigho

208 We detected persistent infections of Mycoplasma ovipneumoniae, the primary causative agent of

209 Based upon DNA sequence analysis, a Mycoplasma ovis-like species was the most prevalent orga

210 we selected Haemophilus influenzae (HI) and Mycoplasma penetrans (MP) for targeted qPCR.

211 The epidemiology of Mycoplasma pneumoniae (Mp) among US children (<18 years)

212 eliable signs or symptoms that differentiate Mycoplasma pneumoniae (Mp) infection in community-acquir

213 Mycoplasma pneumoniae (Mp) infections cause tracheobronc

214 Mycoplasma pneumoniae (MP) is considered a common cause

215 ecently demonstrated that the measurement of Mycoplasma pneumoniae (Mp)-specific immunoglobulin (Ig)M

216 athogens Staphylococcus aureus (SaEf-Tu) and Mycoplasma pneumoniae (MpnEf-Tu), and the porcine pathog

217 indicate the extent that macrolide-resistant Mycoplasma pneumoniae (MRMp) occurs in the United States

218 urine pneumococcal and legionella antigens, Mycoplasma pneumoniae and Chlamydia pneumoniae antibodie

219 Airway Mycoplasma pneumoniae and human rhinovirus (HRV) infecti

220 these processes in the pathogenic bacterium Mycoplasma pneumoniae and its close relatives have also

221 n technology, was used to initially identify Mycoplasma pneumoniae as the causative agent in this out

222 Mycoplasma pneumoniae ASCs measured by enzyme-linked imm

223 Mycoplasma pneumoniae ASCs of the isotype IgM were found

224 Mycoplasma pneumoniae ASCs were detected from 2 days to

225 Mycoplasma pneumoniae ASCs were undetectable in HCs, in

226 preceding respiratory tract infections with Mycoplasma pneumoniae have been reported in some cases,

227 clinically concomitant with either positive Mycoplasma pneumoniae IgM or PCR testing from January 1,

228 ectrum of neurologic disease attributable to Mycoplasma pneumoniae in children is incompletely unders

229 to regulate various immune responses to live Mycoplasma pneumoniae in SP-A knockout mice and RAW 264.

230 Studies on Mycoplasma pneumoniae in Thailand have focused on urban

231 onic eosinophilic pneumonia complicated with Mycoplasma pneumoniae infection was diagnosed on the bas

232 iratory distress syndrome (CARDS) toxin from Mycoplasma pneumoniae is a 591-amino-acid virulence fact

233 Mycoplasma pneumoniae is a cell wall-less bacterial path

234 Mycoplasma pneumoniae is a leading cause of community-ac

235 Mycoplasma pneumoniae is a leading cause of respiratory

236 Mycoplasma pneumoniae is a major cause of community-acqu

237 Mycoplasma pneumoniae is a major human respiratory patho

238 Mycoplasma pneumoniae is an atypical bacterial respirato

239 Mycoplasma pneumoniae is an extracellular pathogen that

240 Mycoplasma pneumoniae is an important cause of respirato

241 Macrolide-resistant Mycoplasma pneumoniae is an increasing problem worldwide

242 Mycoplasma pneumoniae is the leading cause of bacterial

243 Early distinction between severe Mycoplasma pneumoniae pneumonia (MPP) and mild MPP is st

244 be involved in the pathogenesis of children Mycoplasma pneumoniae pneumonia (MPP).

245 t of detection was </=88 CFU/reaction for 10 Mycoplasma pneumoniae reference strains.

246 Mycoplasma pneumoniae should be included in the differen

247 cell cultures infected with a PyNP-deficient Mycoplasma pneumoniae strain.

248 lla pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae This multicenter evaluation provid

249 Mycoplasma pneumoniae was detected in 1.9% of patients a

250 Mycoplasma pneumoniae was more common among children 5 y

251 oach using the genome-reduced human pathogen Mycoplasma pneumoniae We combined whole-cell cross-linki

252 Mycoplasma pneumoniae, an atypical human pathogen, has b

253 Mycoplasma pneumoniae, long appreciated as one of the tr

254 mophilus influenzae, Neisseria meningitidis, Mycoplasma pneumoniae, Mycobacterium tuberculosis, and B

255 ted six commercial molecular tests targeting Mycoplasma pneumoniae, namely, the BioFire FilmArray res

256 ly become available for Escherichia coli and Mycoplasma pneumoniae, yielding 443 and 116 heteromultim

257 Mycoplasma pneumoniae-specific ASCs are short-lived and

258 ld-type copies, including the ruvA gene from Mycoplasma pneumoniae.

259 uenza, 6% herpes simplex virus (HSV), and 6% Mycoplasma pneumoniae; 25% (95% CI, 20%-30%) had immune-

260 Hemotropic mycoplasmas, previously classified in the genus Eperythr

261 remodeling in the respiratory tract by using Mycoplasma pulmonis infection as a model of sustained in

262 ANG2 drove vascular remodeling during Mycoplasma pulmonis infection by acting as a Tie2 antago

263 o these changes in airway inflammation after Mycoplasma pulmonis infection in mice.

264 r baseline conditions and 3 to 28 days after Mycoplasma pulmonis infection, using prospero heomeobox

265 ut were efficiently catabolized (removed) by mycoplasma PyNP.

266 ain were annotated using the fully annotated Mycoplasma reference genome.

267 teria classified as Mollicutes, and known as mycoplasma-related endobacteria (MRE).

268 and they themselves are hosts for Mollicutes/Mycoplasma-related endobacteria (MRE).

269 Mycoplasma-related endobacterium sequences were identifi

270 traits associated with enhanced virulence in Mycoplasmas, relative to isolates from sham-treated bird

271 acrophages (HD-11) with TECs exposed to live mycoplasma revealed the upregulation of several proinfla

272 Here, we found VP of Mycoplasma, Rhizobiales, and Rickettsiales showed signif

273 case where metagenomics was used to identify Mycoplasma salivarium as a novel PJI pathogen in a patie

274 A previously undescribed Mycoplasma sp. sequence was found in two guignas and one

275 use it has been reported that some commensal mycoplasma species (including M. hyorhinis) preferential

276 , and no cross-reactions occurred with other Mycoplasma species colonizing birds.

277 Protein M as well as its orthologs in other Mycoplasma species could become invaluable reagents in t

278 the most virulent and economically important Mycoplasma species for poultry worldwide.

279 The most common feline Mycoplasma species in guigna and domestic cats were Cand

280 oduction/cytotoxicity and virulence for this Mycoplasma species in its natural host.

281 , but incompletely characterized, hemotropic Mycoplasma species was also documented.

282 oss-reactivity was observed against 17 other Mycoplasma species, 27 common respiratory agents, or hum

283 ion and sequencing revealed a putative novel mycoplasma species.

284 ified lineage sister to the hominis group of Mycoplasma species.

285 ence in vivo have never been assessed in any Mycoplasma species.

286 s and other had high abundance of an unknown Mycoplasma species.

287 erwent routine processing with subculture on Mycoplasma-specific Hayflick agar.

288 Although membrane proteins of Mycoplasma spp. are thought to play crucial roles in hos

289 arthropod vectors that can harbor hemotropic Mycoplasma spp. should be considered during epidemiologi

290 pathogens, including Legionella pneumophila, Mycoplasma spp., Ureaplasma spp., Bacteroides spp., and

291 ransplanted into recipient cells yielded two mycoplasma strains.

292 Several mycoplasmas, such as the emergent human pathogen Mycopla

293 ed from (AG)n-Di-SSRs between VP and N_VP in Mycoplasma suggested the potential role of (AG)n-Di-SSRs

294 methods available for product sterility and Mycoplasma testing.

295 e proposed to be virulence traits in minimal Mycoplasma that cause disease in humans and animals.

296 There appears to be selective pressure for mycoplasmas to retain the genes needed for glycerol meta

297 No cross-reactions were detected with other mycoplasmas, ureaplasmas, other bacterial species, virus

298 ton model in eukaryotic flagella and gliding Mycoplasma We observed high nucleotide selectivity for A

299 bacterial genera Mannheimia, Moraxella, and Mycoplasma were significantly higher in diseased versus

300 Genital mycoplasmas, which can be vertically transmitted, have b